Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial

  1. Drakaki, A.
  2. Kirby, C.J.
  3. Van Der Heijden, M.S.
  4. Petrylak, D.P.
  5. Powles, T.
  6. Chi, K.N.
  7. Fléchon, A.
  8. Necchi, A.
  9. Géczi, L.
  10. Lee, J.-L.
  11. Gakis, G.
  12. Bracarda, S.
  13. Chowdhury, S.
  14. Lin, C.-C.
  15. Keizman, D.
  16. Vaishampayan, U.N.
  17. Zimmermann, A.H.
  18. Bell-Mcguinn, K.
  19. Castellano, D.
Revista:
Bladder Cancer

ISSN: 2352-3735,  2352-3727

Any de publicació: 2020

Volum: 6

Número: 1

Pàgines: 43-52

Tipus: Article

DOI: 10.3233/BLC-190252 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus